<p>Global healthcare major Johnson & Johnson on Monday said it remains committed to bringing its single-dose Covid-19 vaccine to India and looks forward to ongoing discussions with the Indian government.</p>.<p>The statement comes after the company withdrew its application to conduct bridging clinical studies of its vaccine in India after the government waived the requirement of such trials for foreign-approved vaccines.</p>.<p>"Johnson & Johnson remains committed to bringing its single- dose Covid-19 vaccine to the people of India.</p>.<p>"Since the Drugs Controller General of India (DCGI) recently directed that there is no longer a requirement to conduct bridging clinical studies of Covid-19 vaccines in India, Johnson & Johnson withdrew its application to conduct these studies," the company said in an emailed statement.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/national/north-and-central/covid-19-wrap-up-india-may-see-new-smaller-wave-soon-1015472.html" target="_blank">Covid-19 Wrap-up: India may see new smaller wave soon</a></strong></p>.<p>According to the latest recommendations of the Subject Expert Committee (SEC) meeting to examine Covid-19 related proposals under the accelerated approval process, Johnson & Johnson had informed that it was withdrawing its proposal. </p>.<p>"We look forward to ongoing discussions with the Government of India and will continue to explore how to accelerate availability of the Johnson & Johnson Covid-19 vaccine in India," the company said.</p>.<p>India registered 40,134 fresh Covid-19 infections, pushing its virus tally to 3,16,95,958, while the number of active cases registered an increase for the sixth consecutive day, according to the Union Health Ministry data updated on Monday.</p>.<p>The death toll from the pandemic climbed to 4,24,773 with 422 daily fatalities. </p>
<p>Global healthcare major Johnson & Johnson on Monday said it remains committed to bringing its single-dose Covid-19 vaccine to India and looks forward to ongoing discussions with the Indian government.</p>.<p>The statement comes after the company withdrew its application to conduct bridging clinical studies of its vaccine in India after the government waived the requirement of such trials for foreign-approved vaccines.</p>.<p>"Johnson & Johnson remains committed to bringing its single- dose Covid-19 vaccine to the people of India.</p>.<p>"Since the Drugs Controller General of India (DCGI) recently directed that there is no longer a requirement to conduct bridging clinical studies of Covid-19 vaccines in India, Johnson & Johnson withdrew its application to conduct these studies," the company said in an emailed statement.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/national/north-and-central/covid-19-wrap-up-india-may-see-new-smaller-wave-soon-1015472.html" target="_blank">Covid-19 Wrap-up: India may see new smaller wave soon</a></strong></p>.<p>According to the latest recommendations of the Subject Expert Committee (SEC) meeting to examine Covid-19 related proposals under the accelerated approval process, Johnson & Johnson had informed that it was withdrawing its proposal. </p>.<p>"We look forward to ongoing discussions with the Government of India and will continue to explore how to accelerate availability of the Johnson & Johnson Covid-19 vaccine in India," the company said.</p>.<p>India registered 40,134 fresh Covid-19 infections, pushing its virus tally to 3,16,95,958, while the number of active cases registered an increase for the sixth consecutive day, according to the Union Health Ministry data updated on Monday.</p>.<p>The death toll from the pandemic climbed to 4,24,773 with 422 daily fatalities. </p>